InnoCare Pharma Limited (SHA:688428)
China
· Delayed Price · Currency is CNY 23.98
-0.55 (-2.24%)
At close: Jun 5, 2025, 2:57 PM CST
InnoCare Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 6,327 | 6,241 | 8,287 | 8,743 | 5,929 | 3,970 | Upgrade
|
| Short-Term Investments | - | - | - | 313.29 | - | - | Upgrade
|
| Trading Asset Securities | 681.19 | 759.18 | - | - | 317.06 | - | Upgrade
|
| Cash & Short-Term Investments | 7,008 | 7,000 | 8,287 | 9,056 | 6,246 | 3,970 | Upgrade
|
| Cash Growth | -14.56% | -15.53% | -8.49% | 45.00% | 57.34% | 67.35% | Upgrade
|
| Accounts Receivable | 363.57 | 351 | 276.38 | 127.82 | 45.27 | 0.15 | Upgrade
|
| Other Receivables | 0.27 | 0.05 | 31.34 | 0.99 | 62.27 | 78.1 | Upgrade
|
| Receivables | 363.83 | 351.05 | 307.71 | 128.82 | 107.55 | 78.25 | Upgrade
|
| Inventory | 97.07 | 95.58 | 119.09 | 65.32 | 9.92 | 1.88 | Upgrade
|
| Other Current Assets | 428.46 | 373.56 | 51.38 | 49.37 | 53.87 | 42.46 | Upgrade
|
| Total Current Assets | 7,897 | 7,820 | 8,765 | 9,300 | 6,417 | 4,092 | Upgrade
|
| Property, Plant & Equipment | 797.07 | 814.27 | 798.5 | 681.5 | 566.08 | 403.13 | Upgrade
|
| Long-Term Investments | 0.48 | 0.4 | 5.66 | 11.71 | 326.1 | 1.16 | Upgrade
|
| Goodwill | 3.12 | 3.12 | 3.12 | 3.12 | 3.13 | 3.13 | Upgrade
|
| Other Intangible Assets | 255.97 | 258.14 | 266.03 | 273.14 | 34.17 | 37.02 | Upgrade
|
| Long-Term Deferred Charges | - | 31.94 | 33.3 | 39.82 | - | - | Upgrade
|
| Other Long-Term Assets | 459.53 | 479.43 | 48.06 | 19.77 | 50.95 | 1.05 | Upgrade
|
| Total Assets | 9,414 | 9,407 | 9,920 | 10,329 | 7,398 | 4,538 | Upgrade
|
| Accounts Payable | 165.68 | 128.36 | 134.9 | 118.6 | 84.6 | 5.52 | Upgrade
|
| Accrued Expenses | 41.17 | 127.52 | 100.06 | 119.46 | 97.5 | 50.21 | Upgrade
|
| Short-Term Debt | 80.06 | 137.45 | - | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 95.49 | 56.35 | 1,256 | 1,197 | - | - | Upgrade
|
| Current Portion of Leases | - | 31.61 | 23.23 | 20.11 | 20.34 | 6.83 | Upgrade
|
| Current Unearned Revenue | - | - | - | 4.24 | 19.48 | 6.65 | Upgrade
|
| Other Current Liabilities | 583.21 | 567.99 | 567.66 | 608.09 | 107.39 | 35.25 | Upgrade
|
| Total Current Liabilities | 1,007 | 1,049 | 2,082 | 2,068 | 329.3 | 104.45 | Upgrade
|
| Long-Term Debt | 1,344 | 1,322 | 331.88 | 287.76 | 1,238 | 1,150 | Upgrade
|
| Long-Term Leases | 25.21 | 27.44 | 43.65 | 35.44 | 47.44 | 17.17 | Upgrade
|
| Long-Term Unearned Revenue | 270.74 | 263 | 281.78 | 293.58 | 123.61 | 100 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | - | 6.04 | Upgrade
|
| Total Liabilities | 2,648 | 2,662 | 2,739 | 2,684 | 1,739 | 1,377 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | - | 12,111 | 12,150 | 12,082 | 9,372 | 6,743 | Upgrade
|
| Retained Earnings | -5,502 | -5,520 | -5,080 | -4,448 | -3,536 | -3,544 | Upgrade
|
| Treasury Stock | -9.01 | -3.1 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | 12,260 | 137.99 | 77.23 | -36.31 | -230.85 | -95.05 | Upgrade
|
| Total Common Equity | 6,749 | 6,725 | 7,148 | 7,597 | 5,605 | 3,104 | Upgrade
|
| Minority Interest | 17.14 | 20.63 | 32.86 | 47.23 | 54.36 | 56.49 | Upgrade
|
| Shareholders' Equity | 6,766 | 6,746 | 7,181 | 7,644 | 5,659 | 3,161 | Upgrade
|
| Total Liabilities & Equity | 9,414 | 9,407 | 9,920 | 10,329 | 7,398 | 4,538 | Upgrade
|
| Total Debt | 1,545 | 1,575 | 1,655 | 1,540 | 1,306 | 1,174 | Upgrade
|
| Net Cash (Debt) | 5,463 | 5,425 | 6,632 | 7,516 | 4,940 | 2,796 | Upgrade
|
| Net Cash Growth | -29.89% | -18.20% | -11.76% | 52.15% | 76.67% | - | Upgrade
|
| Net Cash Per Share | 3.22 | 3.20 | 3.89 | 5.09 | 3.62 | 2.89 | Upgrade
|
| Filing Date Shares Outstanding | 1,797 | 1,762 | 1,763 | 1,764 | 1,500 | 1,289 | Upgrade
|
| Total Common Shares Outstanding | 1,797 | 1,762 | 1,763 | 1,764 | 1,500 | 1,289 | Upgrade
|
| Working Capital | 6,890 | 6,771 | 6,683 | 7,232 | 6,088 | 3,988 | Upgrade
|
| Book Value Per Share | 3.76 | 3.82 | 4.05 | 4.31 | 3.74 | 2.41 | Upgrade
|
| Tangible Book Value | 6,490 | 6,464 | 6,879 | 7,321 | 5,567 | 3,064 | Upgrade
|
| Tangible Book Value Per Share | 3.61 | 3.67 | 3.90 | 4.15 | 3.71 | 2.38 | Upgrade
|
| Buildings | - | 422.73 | 364.63 | 224.41 | 81.04 | - | Upgrade
|
| Machinery | - | 362.86 | 302.01 | 248.14 | 127.57 | 13.91 | Upgrade
|
| Construction In Progress | - | 138.86 | 166.91 | 197.65 | 230.72 | 296.93 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 6.68 | 1.08 | Upgrade
|
Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.